1,094
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2333104 | Received 27 Nov 2023, Accepted 18 Mar 2024, Published online: 07 Apr 2024

References

  • Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325–10. doi:10.1016/j.chom.2020.02.001.
  • WHO Coronavirus (COVID-19) Dashboard. WHO coronavirus (COVID-19) dashboard with vaccination data. 2023.
  • Centers for Disease Control and Prevention. Updated healthcare infection prevention and control recommendations in response to COVID-19 vaccination. 2021.
  • Grenfell R, Drew T. Here’s why the WHO says a coronavirus vaccine is 18 months away. 2020. https://theconversation.com/heres-why-the-who-says-a-coronavirus-vaccine-is-18-months-away-131213‏.
  • Fortner A, Schumacher D. First COVID-19 vaccines receiving the US FDA and EMA emergency use authorization. Discoveries (Craiova). 2021;9(1):e122. doi:10.15190/d.2021.1.
  • Health JMo. COVID-19 statistical report – Jordan; 2021.
  • Health JMo. Vaccines and medicines for corona virus. Jordan Food and Drug Administration; 2021.
  • Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327–31. doi:10.23812/CONTI-E.
  • Chaurasia RK, Shirsath KB, Sapra BK. Protocol for one-step selective lysis of red blood cells and platelets with long-term preservation of white blood cells (human) at ambient temperature. STAR Protoc. 2021;2(4):100834. doi:10.1016/j.xpro.2021.100834.
  • Pospichalova V, Svoboda J, Dave Z, Kotrbova A, Kaiser K, Klemova D, Bryja V. Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. J Extracell Vesicles. 2015;4(1):25530. doi:10.3402/jev.v4.25530.
  • Mousset CM, Hobo W, Woestenenk R, Preijers F, Dolstra H, van der Waart AB. Comprehensive phenotyping of T cells using flow cytometry. Cytometry A. 2019;95(6):647–54. doi:10.1002/cyto.a.23724.
  • Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, Asadi-Aliabadi M, Nojomi M. Adverse effects followingCOVID-19 vaccination in Iran. BMC Infect Dis. 2022;22(1):1–8. doi:10.1186/s12879-022-07411-5.
  • Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10(7):1–18. doi:10.3390/jcm10071428.
  • Abu-Hammad O, Alduraidi H, Abu-Hammad S, Alnazzawi A, Babkair H, Abu-Hammad A, Nourwali I, Qasem F, Dar-Odeh N. Side effects reported by jordanian healthcare workers who received COVID-19 vaccines. Nato Adv Sci Inst Se. 2021;9(6):1–10. doi:10.3390/vaccines9060577.
  • Sønderskov KM, Dinesen PT, Østergaard SD. Sustained COVID-19 vaccine willingness after safety concerns over the oxford-astrazeneca vaccine. Dan Med J. 2021;68:5–11.
  • Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W, et al. Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA - J Am Med Assoc. 2020;324(10):951–60. doi:10.1001/jama.2020.15543.
  • Oghazian S, Tamanaei TT, Haghighi R, Faregh M, Oghazian MB. Side effects of Sputnik V, Oxford–AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran. Int Immunopharmacol. 2023;117:109784‏. doi:10.1016/j.intimp.2023.109784.
  • Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, et al. Vaccine sideeffects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–49. doi:10.1016/S1473-3099(21)00224-3.
  • Anzalone AJ, Sun J, Vinson AJ, Beasley WH, Hillegass WB, Murray K, Hendricks BM, Haendel M, Geary CR, Bailey KL, et al. Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: a retrospective cohort study from the national COVID cohort collaborative. PLoS One. 2023;18(1):e0279968‏. doi:10.1371/journal.pone.0279968.
  • Iguacel I, Maldonado AL, Ruiz-Cabello AL, Casaus M, Moreno LA, Martínez-Jarreta B. Association between COVID-19 vaccine side effects and body mass index in Spain. Nato Adv Sci Inst Se. 2021;9(11):1321‏. doi:10.3390/vaccines9111321.
  • Omersel J, Karas Kuželički N. Vaccinomics and adversomics in the era of precision medicine: a review based on HBV, MMR, HPV, and COVID-19 vaccines. J Clin Med. 2020;9(11):3561‏. doi:10.3390/jcm9113561.
  • Callaway E, Mallapaty S. What scientiests do and don’t know about the Oxford AstraZeneca COVID vaccine. Nature. 2021;592(7844):15–16. doi:10.1038/d41586-021-00241-6.
  • Kaminska D, Contreras-Gardu I, Krams R, Moore FR, Birbele E, Elferts I, Skrinda J. Psychoneuroendocrinology socioeconomic position, immune function, and its physiological markers. Psychoneuroendocrinology. 2021;127:127. doi:10.1016/j.psyneuen.2021.105202.
  • Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Choi P, Althaus K, Ahlen MT, Sharma R, Grace RF, Bakchoul T. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC subcommittee on platelet immunology. J Thromb Haemost. 2021;19(6):1585–8. doi:10.1111/jth.15341.
  • Greinacher A, Thiele T, Warkentin TE, Weisser K. A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia following coronavirus-19 vaccination. Res Sq. 2021;preprint:1–8.
  • Warkentin TE, Cuker A. COVID-19: vaccine-induced immune thrombotic thrombocytopenia (VITT). Update May, 7. 2021.
  • Male V. Menstrual changes after COVID-19 vaccination. BMJ. 2021;374:1–2. doi:10.1136/bmj.n2211.
  • Cheng H, Peng Z, Luo W, Si S, Mo M, Zhou H, Xin X, Liu H, Yu Y. Efficacy and safety of COVID-19 vaccines in phase iii trials: a meta-analysis. Nato Adv Sci Inst Se. 2021;9(6):1–14. doi:10.3390/vaccines9060582.
  • Abdel-Qader DH, Abdel-Qader H, Silverthorne J, Kongkaew C, Meslamani AZA, Hayajneh W, AbuRuz S, Hamadi S, Abu-Qatouseh L, Awad R, Al Nsour M. Real-world effectiveness of four types of COVID-19 vaccines. Vaccines. 2023;11(5):985‏. doi:10.3390/vaccines11050985.
  • Vályi-Nagy I, Matula Z, Gönczi M, Tasnády S, Bekő G, Réti M, Ajzner É, Uher F. Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans. GeroScience. 2021;43(5):2321–31. doi:10.1007/s11357-021-00471-6.
  • Cavanaugh AM, Spicer KB, Thoroughman D, Glick C, Winter K. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination—Kentucky, May–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(32):1081–3. doi:10.15585/mmwr.mm7032e1.